Active Ingredient(s): Rituximab-pvvr
FDA Approved: * July 23, 2019
Pharm Company: * PFIZER INC
Category: Cancer

Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer.[9] It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in non-geriatric patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura, pemphigus vulgaris, myasthenia gravis and Epstein–Barr virus-positive mucocutaneous ulcers.[9][10&... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Ruxience 100 mg/10ml Intravenous Injection, Solution
NDC: 0069-0238
Pfizer Laboratories Div Pfizer Inc
Ruxience 500 mg/50ml Intravenous Injection, Solution
NDC: 0069-0249
Pfizer Laboratories Div Pfizer Inc

Related Brands

Drugs with the same active ingredients